Trial intelligence / Profile preview

ASPIRE-AF: NOACs for Stroke Prevention in Perioperative Atrial Fibrillation

NCT03968393Phase 4Recruiting

Sponsor
Population Health Research Institute
Start
Jun 2019
Primary completion
Dec 2028
Countries
18
01

Overview

Phase 4, randomised, open-label trial in stroke and systemic embolism, sponsored by Population Health Research Institute. Primary endpoint: Incidence of Non-hemorrhagic stroke or systemic embolism at 24 months. Started Jun 2019; status: recruiting.

02

Conditions

strokesystemic embolism

Beyond the preview

Go deeper on NCT03968393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03968393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call